22 October 2026 The socio-economic impact of age-related macular degeneration (AMD) in Bulgaria, Germany and USA; A disease burden assessment of GA and nAMD
22 October 2026 Socioeconomic burden of advanced Age-related Macular Degeneration (AMD) in the United States of America (USA), Germany and Bulgaria
22 October 2026 Enhancing Clinician-Patient Communication in Age Related Macular Degeneration (AMD): Insights from Patients and Clinicians
22 October 2026 Accuracy and Readability of ChatGPT-4o Generated Responses to queries on Age-related Macular Degeneration for Patient Education and Counselling
22 October 2026 Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis
22 October 2026 Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries
22 October 2026 A cost of illness model to estimate the annual societal costs of X-linked retinitis pigmentosa (XLRP) in the United Kingdom (UK)
22 October 2026 Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US